Presepsin holds promise as a biomarker for early-onset sepsis (EOS), a systematic review and meta-analysis confirmed. Across a dozen clinical trials, presepsin had a pooled sensitivity of 0.93 for the ...

From 1996 through 2007, the Pediatrix Medical Group cared for 119,130 late preterm infants ≤3 days of life and 106,142 late preterm infants 4 to 120 days of life in the NICUs. Infants between the ages ...

In a recent study published in Jama Network Open, researchers investigated the effects of early postnatal exposure to antibiotics among infants in the participating networks of high-income countries.

Background: Sepsis in the first 3 days of life is a leading cause of morbidity and mortality among infants. Group B Streptococcus (GBS), historically the primary cause of early-onset sepsis (EOS), has ...

Researchers reveal that CRP levels naturally rise after birth, reducing the test’s accuracy in full-term babies but may help identify infection risk in preterm infants. Neonatal EOS, a severe ...

Please provide your email address to receive an email when new articles are posted on . Enhanced neutrophil CD64, or nCD64, may be an important marker for diagnosing infants with sepsis and may help ...

A genetic signature in newborns can predict neonatal sepsis before symptoms even start to show, according to a new study. The study— Predictive gene expression signature diagnoses neonatal sepsis ...

Sepsis, a life-threatening condition caused by the body’s extreme response to infection, remains the third leading cause of newborn death in the country, according to local studies. The condition ...

Sepsis is a potentially fatal or life changing syndrome wherein the body responds to an infection with a systemic immune response. Many clinicians consider sepsis to have three stages, starting with ...

Sepsis is a life threatening illness that develops when an existing infection triggers an extreme immune system response in your body. When you experience an infection, your immune system releases ...